In a homocysteine-induced cognitive impairment model, an independent risk factor for AD, betaine alleviated cognitive impairment by inhibiting the NLRP3/caspase-1/GSDMD pathway in an m6A-YTHDF2-dependent manner, thereby suppressing microglial pyroptosis (187). This evidence concerns the gene GSDMD and Cognitive impairment.